(Date:12/15/2009)... have been developed and are opening up a new area ... NeedleProbes’ cylindrical geometry enables researchers to measure surface tension, contact ... a single force distance curve. , ... ... NeedleProbes are enabling unique measurements at the liquid/air interface. ...
(Date:12/15/2009)... Center for Business Intelligence (CBI), a division ... the full agenda for the 6th ... The forum will take place at the ... Over 1,500 senior-level Finance, Accounting, Audit and ... since its inception, and this year,s meeting ...
(Date:12/15/2009)... 15 , ... Evaluate the Ability of,Cardiopoietic Cells to Restore Cardiac ... a leading Belgian biotechnology company specialising,in cell-based therapies ... it has completed, two months ahead of schedule,enrolment ... II/III trial of C-Cure, a,unique stem cell therapy ...
(Date:12/14/2009)... -- Vermillion, Inc. (Pink Sheets: VRML), a ... Wallen, Ph.D. Chief Scientific Officer, Senior Vice ... will be joining its board of directors ... ,, "Bill brings more than 20 years ... biotechnology," said Gail Page, Vermillion Executive Chairperson. ...
Breaking Biology Technology:New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4... MELBOURNE, Australia, March 17 , - New ... QuoNova Accelerating Compound Development Towards Commercialization, QuoNova ... and,efficacious anti-virulence agents in the global fight against ... appointed three new,senior executives in global roles to ...
... March 17 The rating,agency Moody,s has raised ... to,Ba2 with "Outlook stable"., As a result, ... its,refinancing possibilities are substantially enhanced. Moody,s justifies,this step ... as,a result of successful acquisitions and in view ...
... Masimo Corporation,(Nasdaq: MASI ), the inventor of Pulse ... that it is scheduled,to present at the Citi Investment Research ... in Las Vegas, NV on Wednesday, March,19, 2008 at 2:25 ... P. de,Raad, Executive Vice President and CFO, will be presenting., ...
Other Biology Technology:QuoNova Global Executive Appointments 2QuoNova Global Executive Appointments 3QuoNova Global Executive Appointments 4Moody's Raises Rating for Gerresheimer 2Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference 2Goat polyclonal to FBXO2 ( Abpromise for all tested applications). entrezGeneID: 26232 SwissProtID: Q9UK22...
Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...
Mouse monoclonal [15-2] to Mannose Receptor (Biotin) ( Abpromise for all tested applications). entrezGeneID: 4360 SwissProtID: P22897...
SAPK/JNK Antibody...
Biology Products:Biology NavigationMedical Navigation